Latest News about FDA
Recent news which mentions FDA
U.S. FDA Rejects HUTCHMED's New Drug Application For Surufatinib In Neuroendocrine Tumors
May 02, 2022
Tickers
HCM
From Benzinga
From Benzinga
From Benzinga
From Benzinga
Lyra Therapeutics Presents LYR-210 Positive Data from LANTERN Phase 2 Study for Chronic Rhinosinusitis
April 29, 2022
Tickers
LYRA
From Benzinga
From Benzinga
U.S. FDA Approves Bristol Myers Squibb's Camzyos™ (mavacamten) for the Treatment of Adults With obstructive HCM
April 28, 2022
Tickers
BMY
From Benzinga
U.S. FDA removes Clinical Hold on Finch's investigational new drug (IND) application for CP101
April 28, 2022
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.